These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7743639)
1. The pathogenic role of the NMDA receptor in hyperthermia-induced seizures in developing rats. Morimoto T; Kida K; Nagao H; Yoshida K; Fukuda M; Takashima S Brain Res Dev Brain Res; 1995 Feb; 84(2):204-7. PubMed ID: 7743639 [TBL] [Abstract][Full Text] [Related]
2. Antiepileptic effects of MK-801, a noncompetitive NMDA-receptor antagonist, in the low-frequency kindling model of epilepsy. Minabe Y; Emori K; Shibata R; Kurachi M Jpn J Psychiatry Neurol; 1992 Sep; 46(3):755-61. PubMed ID: 1487858 [TBL] [Abstract][Full Text] [Related]
3. The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling. Gilbert ME Epilepsy Res; 1994 Feb; 17(2):145-56. PubMed ID: 8194510 [TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Sato K; Morimoto K; Okamoto M Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606 [TBL] [Abstract][Full Text] [Related]
5. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats. Trommer BL; Pasternak JF Brain Res Dev Brain Res; 1990 May; 53(2):248-52. PubMed ID: 2162746 [TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. McNamara JO; Russell RD; Rigsbee L; Bonhaus DW Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782 [TBL] [Abstract][Full Text] [Related]
7. Selective alterations in binding kinetic parameters and allosteric regulation of N-methyl-D-aspartate receptors after prolonged seizures in the developing rat brain. Doriat JF; Cortey A; Daval JL Pediatr Res; 1998 Mar; 43(3):415-20. PubMed ID: 9505283 [TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669 [TBL] [Abstract][Full Text] [Related]
9. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam. Baran H; Löscher W; Mevissen M Brain Res; 1994 Aug; 652(2):195-200. PubMed ID: 7953730 [TBL] [Abstract][Full Text] [Related]
10. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures. Gilbert ME Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609 [TBL] [Abstract][Full Text] [Related]
11. Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Martin DC; Plagenhoef M; Abraham J; Dennison RL; Aronstam RS Biochem Pharmacol; 1995 Mar; 49(6):809-17. PubMed ID: 7702639 [TBL] [Abstract][Full Text] [Related]
12. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats. Wlaź P; Ebert U; Potschka H; Löscher W Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648 [TBL] [Abstract][Full Text] [Related]
13. Chronic neonatal MK-801 administration leads to a long-lasting increase in seizure sensitivity during the early stages of hippocampal kindling. Gorter JA; Titulaer M; Bos NP; Huisman E Neurosci Lett; 1991 Dec; 134(1):29-32. PubMed ID: 1840001 [TBL] [Abstract][Full Text] [Related]
14. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Morimoto K; Katayama K; Inoue K; Sato K Pharmacol Biochem Behav; 1991 Dec; 40(4):893-9. PubMed ID: 1840082 [TBL] [Abstract][Full Text] [Related]
15. NMDA receptors in the inferior colliculus are critically involved in audiogenic seizures in the adult rats with neonatal hypothyroidism. Higashiyama A; Ishida N; Nishimura T; Yasuda S; Kuroda Y; McEwen BS; Kato N Exp Neurol; 1998 Sep; 153(1):94-101. PubMed ID: 9743570 [TBL] [Abstract][Full Text] [Related]
16. Effects of acute treatment and long-term treatment with MK-801 against amygdaloid kindled seizures in rats. Yoshida M; Ohkoshi N; Tsuru N Epilepsy Res; 1997 Mar; 26(3):407-13. PubMed ID: 9127721 [TBL] [Abstract][Full Text] [Related]
17. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Löscher W; Rundfeldt C; Hönack D Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524 [TBL] [Abstract][Full Text] [Related]
18. Kindling induced by pentylenetetrazole in rats is not directly associated with changes in the expression of NMDA or benzodiazepine receptors. Atack JR; Cook SM; Hutson PH; File SE Pharmacol Biochem Behav; 2000 Apr; 65(4):743-50. PubMed ID: 10764932 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of inhibition with perforant path kindling: an NMDA-receptor dependent process. Gilbert ME Brain Res; 1991 Nov; 564(1):109-16. PubMed ID: 1838018 [TBL] [Abstract][Full Text] [Related]
20. MK-801 prevents chemical kindling induced by pentylenetetrazol in rats. Giorgi O; Orlandi M; Lecca D; Corda MG Eur J Pharmacol; 1991 Feb; 193(3):363-5. PubMed ID: 1647322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]